Bravida Denmark to install complete technical solutions for AGC Biologics A/S with an order value of approximately DKK 150 million

AGC Biologics A/S will include production facilities, quality laboratories, storage areas and cargo space. The building also contains offices, a customer centre and a basement with storage and parking. Bravida’s assignment includes ventilation, water, wastewater, heating, cooling (excluding the central cooling facility), building electricity, IT infrastructure, security, BMS and sprinklers. Bravida will also supply solar cells for the building. 

“This is a large and exciting assignment, in which we will have overall responsibility for the technology combined with coordination between the various technology areas. We already have good experience of this type of project and it forms a further part of our competence development in the pharmaceutical industry,” comments Kurt Kastrup Vestergaard, Regional Manager for the Entreprise Region, Bravida Denmark.

Morten Vilstrup, Project Director at AGC Biologics A/S, comments:

“We are very pleased to have Bravida as our technical contractor, due to the company’s considerable experience with this type of assignment. We look forward to working together.”

The order was included in the first quarter of 2022 and the project is scheduled for completion in the second quarter of 2023. 

For further information, please contact: 
Liselotte Stray
Head of Group Communications
liselotte.stray@bravida.se
+46 (0)76 852 38 11